The effect of cholesterol-lowering treatment on renal function [1]

American Journal of Kidney Diseases

Volumn 47, Issue 3, 2006, Pages 561-

  Liberopoulos, Evagelos N ^a   Mikhailidis, Dimitri P ^a   Athyros, Vasilios G ^b   Elisaf, Moses S ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; COLESTYRAMINE; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; URIC ACID;

CHRONIC KIDNEY DISEASE; DRUG EFFECT; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LETTER; URIC ACID BLOOD LEVEL;

ANTICHOLESTEREMIC AGENTS; CHOLESTYRAMINE; HUMANS; KIDNEY;

EID: 32844456159     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.11.031     Document Type: Letter

References (10)

1. A.V. Kshirsagar, D.A. Shoham, H. Bang, S.L. Hogan, R.J. Simpson Jr, R.E. Colindres The effect of cholesterol reduction with cholestyramine on renal function Am J Kidney Dis 46 2005 812 819
2. B.L. Kasiske, M.P. O'Donell, P.G. Schmitz, W.F. Keane The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease Adv Nephrol Necker Hosp 20 1991 109 125
3. E. Liberopoulos, K. Siamopoulos, M. Elisaf Apolipoprotein E and renal disease Am J Kidney Dis 43 2004 223 233
4. D.C. Wheeler Does lipid-lowering therapy slow progression of chronic kidney disease? Am J Kidney Dis 44 2004 917 920
5. M. Elisaf, D.P. Mikhailidis Statins and renal function Angiology 53 2002 493 502
6. V.G. Athyros, D.P. Mikhailidis, A.A. Papageorgiou The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) study J Clin Pathol 57 2004 728 734
7. V.G. Athyros, M. Elisaf, A.A. Papageorgiou Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease A subgroup analysis of the GREek Atorvastatin and Coronary-heart- disease Evaluation (GREACE) study Am J Kidney Dis 43 2004 589 599
8. M. Epstein, V.M. Campese Pleiotropic effects of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors on renal function Am J Kidney Dis 45 2005 2 14
9. R. Agarwal, T.M. Curley The role of statins in chronic kidney disease Am J Med Sci 330 2005 69 81
10. G. Tonolo, M.G. Melis, M. Formato Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients Eur J Clin Invest 30 2000 980 987